Work

PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies

Year: 2013

Type: review

Source: Annals of Oncology

DOI: 10.1093/annonc/mdt384

Authors: J-m. Lee, J.A. Ledermann, E.C. Kohn

Institutions: National Cancer Institute, Center for Cancer Research, University College London

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Cancer Research UK, National Institutes of Health

Award: G1737400705

OpenAlex ID: W2106951948

FWCI: 3.944

Cites: 77

Cited by: 354

Related to: 10